Valuation: BIONET Corp.

Market Cap 3.13B 97.42M 84.44M 79.16M 72.18M 136M 9.3B 138M 932M 364M 4.65B 366M 358M 15.53B P/E 2024
48.2x
P/E 2025 102x
Enterprise Value 1.84B 57.42M 49.77M 46.66M 42.54M 80.05M 5.48B 81.33M 549M 214M 2.74B 216M 211M 9.15B EV / Sales 2024
2.09x
EV / Sales 2025 3.17x
Free-Float
77.12%
Yield 2024
1.78%
Yield 2025 0.84%
1 day+0.65%
1 week+3.84%
Current month+8.93%
1 month-6.47%
3 months-14.21%
6 months-31.95%
Current year-39.90%
1 week 60.2
Extreme 60.2
62.9
1 month 54
Extreme 54
67.3
Current year 54
Extreme 54
118
1 year 54
Extreme 54
118
3 years 51.92
Extreme 51.917794
162.01
5 years 32.78
Extreme 32.775442
162.01
10 years 20.08
Extreme 20.076125
162.01
Manager TitleAgeSince
Chief Executive Officer - 2006-08-31
Director of Finance/CFO - 2018-03-22
Director TitleAgeSince
Chairman - 2000-07-31
Director/Board Member - 2003-04-10
Director/Board Member 77 2006-11-20
Change 5-day change 1-year change 3-year change Capi.($)
+0.65%+3.84%-16.40%-1.61% 97.42M
+1.17%+1.09%+4.03%+15.74% 49.24B
-1.59%+2.12%+460.02%+573.56% 43.3B
-0.85%+7.95%+15.77%+80.09% 40.48B
-0.08%+3.91%+26.96%+9.86% 39.75B
0.00%+3.59%+20.51%+48.00% 32.67B
-3.61%-1.45% - - 16.23B
-2.52%-0.52%+24.35%+118.05% 16.24B
+0.72%+0.31%+4.94%+21.70% 14.04B
-1.09%+5.94%+81.46%+31.15% 13.43B
Average -0.72%+2.23%+69.07%+99.62% 26.55B
Weighted average by Cap. -0.58%+2.44%+96.50%+134.21%

Financials

2024 2025
Net sales 1.22B 38.05M 32.98M 30.91M 28.19M 53.04M 3.63B 53.89M 364M 142M 1.82B 143M 140M 6.06B 1.24B 38.5M 33.37M 31.28M 28.52M 53.67M 3.67B 54.53M 368M 144M 1.84B 145M 141M 6.14B
Net income 83.7M 2.61M 2.26M 2.12M 1.93M 3.63M 249M 3.69M 24.93M 9.73M 124M 9.78M 9.57M 415M 51.43M 1.6M 1.39M 1.3M 1.19M 2.23M 153M 2.27M 15.32M 5.98M 76.49M 6.01M 5.88M 255M
Net Debt -1.48B -46.08M -39.95M -37.45M -34.14M -64.24M -4.4B -65.27M -441M -172M -2.2B -173M -169M -7.34B -1.28B -39.99M -34.67M -32.5M -29.63M -55.76M -3.82B -56.65M -383M -149M -1.91B -150M -147M -6.37B
Logo BIONET Corp.
BIONET CORP. is a Taiwan-based company principally engaged in the storage and application of hematopoietic stem cells. The Company’s main products include umbilical cord blood stem cells, mesenchymal stem cells, adult peripheral blood stem cells and others. The Company also provides precision medical application, prenatal testing and genetic testing services. The Company operates its businesses mainly in domestic market.
Employees
-
Date Price Change Volume
26-08-13 NT$62.20 +0.65% 92,258
26-08-12 NT$61.80 +0.49% 65,010
26-08-11 NT$61.50 -0.49% 66,574
26-08-10 NT$61.80 +2.66% 138,888
26-08-07 NT$60.20 +0.50% 73,128
  1. Stock Market
  2. Stocks
  3. 1784 Stock